S&P 500   3,294.61 (+0.72%)
DOW   26,664.40 (+0.89%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   3,294.61 (+0.72%)
DOW   26,664.40 (+0.89%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   3,294.61 (+0.72%)
DOW   26,664.40 (+0.89%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   3,294.61 (+0.72%)
DOW   26,664.40 (+0.89%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

ASX:IREIress Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
A$10.60
MA: A$10.60▼
A$10.60
52-Week Range N/A
Volume871,974 shs
Average Volume521,209 shs
Market Capitalization$1.86 billion
P/E Ratio28.19
Dividend Yield4.44%
BetaN/A
IRESS Limited provides information, trading, compliance, order management, portfolio and wealth management, and lending systems and related tools in Australia, New Zealand, Asia, Canada, South Africa, and the United Kingdom. It offers CommPay, a revenue management solution for advisor firms; IRESS Digital, a solution for market data, trading, and charting tools; IRESS Execution Management System, a customizable multi-broker order execution and allocation management solution for buy-side participants; and IRESS Order System, a solution for institutional and retail brokers. The company also provides IRESS Portfolio System, a solution for portfolio management, compliance, and reporting on one platform for institutional and retail portfolio managers; IRESS Pro, a global market information platform for institutional and retail brokers, investment managers, and advisers; private wealth management tools; SmartHub, a managed open trade messaging network that connects buying and selling side participants; and XPLAN, an integrated financial planning software for wealth management and financial planning professionals. In addition, it provides consulting services. The company was formerly known as IRESS Market Technology Limited and changed its name to IRESS Limited in May 2012. IRESS Limited was founded in 1993 and is based in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.50 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Technical & System Software
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolASX:IRE
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.iress.com.au
Phone+61-3-90185800

Debt

Debt-to-Equity Ratio65.59
Current Ratio1.35
Quick Ratio1.02

Price-To-Earnings

Trailing P/E Ratio28.19
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$508.94 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow53.00
Book ValueA$2.52 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares175,923,008
Market Cap$1.86 billion
Next Earnings Date8/21/2020 (Estimated)
OptionableNot Optionable

Receive IRE News and Ratings via Email

Sign-up to receive the latest news and ratings for IRE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Iress (ASX:IRE) Frequently Asked Questions

When is Iress' next earnings date?

Iress is scheduled to release its next quarterly earnings announcement on Friday, August 21st 2020.
View our earnings forecast for Iress.

How were Iress' earnings last quarter?

Iress Ltd (ASX:IRE) released its earnings results on Thursday, February, 21st. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by $0.06.
View Iress' earnings history.

How often does Iress pay dividends? What is the dividend yield for Iress?

Iress announced a Final dividend on Friday, February 21st. Stockholders of record on Friday, March 20th will be paid a dividend of 0.30 per share on Friday, March 20th. This represents a dividend yield of 2.43%. The ex-dividend date is Wednesday, February 26th.
View Iress' dividend history.

Has Iress been receiving favorable news coverage?

Press coverage about IRE stock has trended somewhat positive this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Iress earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.
View the latest news about Iress.

Who are some of Iress' key competitors?

Some companies that are related to Iress include Aurinia Pharmaceuticals (AUP), GB Group (GBG), Micro Focus International (MCRO), Absolute Software (ABT), Emis Group (EMIS), Tecsys (TCS), SDL (SDL), Ideagen (IDEA), Computer Modelling Group (CMG), Dotdigital Group (DOTD), Wandisco (WAND), Microgen (MCGN), IDOX (IDOX), Covata (CVT) and Eckoh (ECK).
View all competitors.

What other stocks do shareholders of Iress own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iress investors own include ADIDAS AG/S (ADDYY), Woolworths Group (WOW), Wirecard (WDI), Tesco (TSCO), TPG Telecom (TPM), Rio Tinto Limited Fully Paid Ord. Shrs (RIO), Linde (LNAGF), Kraft Heinz (KHC), Johnson & Johnson (JNJ) and Coats Group (COA).

Who are Iress' key executives?

Iress' management team includes the following people:
  • Mr. Andrew Leslie Walsh, MD, CEO & Director (Age 45)
  • Mr. John Harris, Chief Financial Officer
  • Mr. Andrew Todd, Chief Technology Officer
  • Mr. Peter Ferguson, Group Gen. Counsel & Company Sec.
  • Mrs. Julia McNeill, Group Exec. of HR

What is Iress' stock symbol?

Iress trades on the ASX under the ticker symbol "IRE."

How big of a company is Iress?

Iress has a market capitalization of $0.00 and generates $508.94 million in revenue each year.

What is Iress' official website?

The official website for Iress is www.iress.com.au.

How can I contact Iress?

Iress' mailing address is The Galleria Shopping Plaza L 18 385 Bourke St, MELBOURNE, VIC 3000, Australia. The company can be reached via phone at +61-3-90185800.

This page was last updated on 8/3/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.